This webinar covered

The momentum of ADCs has continued to assert its dominance in the oncology field throughout 2023, with a huge influx of new developers entering the space and numerous shifts in focus across payloads, combination trials, and Bispecific ADCs. In our recent webinar, we invited attendees to explore the traditional and novel ADC landscapes to maximize their pipelines and discover new opportunities that show huge potential to accelerate drug development.

We asked:

  • The total number of ADC programs has more than doubled in the last 2 years, what are the emerging trends from this recent influx of activity?
  • From Payloads, Linkers, and Targets, to Bispecifics and Combinations, which approaches are seeing the most use and having the most impact across the ADC space?
  • What were the key highlights and updates for ADC development across 2023?


Hosted by


Webinar Leaders

House Speaker

Jia He
ADC Senior Research Lead


Jake Morris
Account Manager

Speak with our team about Beacon ADC

What is Beacon ADC?

Beacon ADC is a manually curated database solution that includes clinical trial and drug records for preclinical, active, approved and discontinued:

  • ADC (Antibody Drug Conjugates)
  • Immunotoxins
  • SMDCs (Small Molecule Drug Conjugates)
  • Radioimmunoconjugates
  • Ligand Conjugated Nanoparticles
  • Liposomal Drug Conjugate and other comparable modalities

Find out more

How Beacon ADC Works

Search the trial and drug landscape by linker, payload and target alongside 20 other search criteria including disease, line of therapy, biomarker, sponsor etc. Instantly extract the data points you need to conduct more complex analyses.

Our unique Milestones filter and visualization highlights past, present, and future drug development milestones including drug and trial readouts, asset history, and regulatory announcements. This enhancement provides an accurate, timely and exhaustive single-drug timeline allowing you to benchmark progress in the ADC space.

Contact Us

What is Beacon?

Beacon is a world leading data analysis tool for preclinical and clinical trial information. With unrivalled granularity of search function, data quality, and exhaustiveness, Beacon provides timely information and gives you confidence to progress your targeted drug therapies to patients.

Learn more about how our clinical trials and drug database solutions can be tailored to your research requirements

Find out more